{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:00:53Z","timestamp":1773766853899,"version":"3.50.1"},"reference-count":25,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.3892\/etm.2011.405","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T09:12:45Z","timestamp":1322903565000},"page":"226-230","source":"Crossref","is-referenced-by-count":15,"title":["Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases"],"prefix":"10.3892","volume":"3","author":[{"given":"KIMITO","family":"YAMADA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MANA","family":"YOSHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"KAISE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHIKO","family":"OGATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOKO","family":"UEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOICHI","family":"TOKUUYE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NORIO","family":"KOHNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"key20180108120947_b1-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","article-title":"The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group","volume":"50","author":"Tong","year":"1982","journal-title":"Cancer"},{"key":"key20180108120947_b2-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"key20180108120947_b3-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10147-007-0726-2","article-title":"Treatment of breast cancer with bone metastasis: bisphosphonate treatment \u2013 current and future","volume":"13","author":"Kohno","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180108120947_b4-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180108120947_b5-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180108120947_b6-etm-03-02-0226","unstructured":"Society of Nuclear Medicine Procedure Guideline for Palliative Treatment of Painful Bone Metastases ver.3.0 (http:\/\/interactive.snm.org\/docs\/pg_ch25_0403.pdf)."},{"key":"key20180108120947_b7-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"BP7","DOI":"10.1007\/s00259-002-1057-1","article-title":"EANM Procedure Guidelines for Treatment of Refractory Metastatic Bone Pain","volume":"30","author":"Silberstein","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"key20180108120947_b8-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bone.2005.12.004","article-title":"Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases","volume":"39","author":"Storto","year":"2006","journal-title":"Bone"},{"key":"key20180108120947_b9-etm-03-02-0226","first-page":"399","article-title":"A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients","volume":"65","author":"Nishio","year":"2005","journal-title":"Nippon Acta Radiologica"},{"key":"key20180108120947_b10-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(05)70206-0","article-title":"Radioisotopes for the palliation of metastatic bone cancer: a systematic review","volume":"6","author":"Finlay","year":"2005","journal-title":"Lancet Oncol"},{"key":"key20180108120947_b11-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00003072-199709000-00005","article-title":"Strontium-89 therapy and imaging with bremsstrahlung in bone metastases","volume":"22","author":"Uchiyama","year":"1997","journal-title":"Clin Nucl Med"},{"key":"key20180108120947_b12-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000011881","article-title":"Strontium-89 chloride in the treatment of bone metastases from breast cancer","volume":"55","author":"Baziotis","year":"1998","journal-title":"Oncology"},{"key":"key20180108120947_b13-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cncr.10437","article-title":"A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone","volume":"94","author":"Akerley","year":"2002","journal-title":"Cancer"},{"key":"key20180108120947_b14-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(00)03639-4","article-title":"Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomized phase II trial","volume":"357","author":"Tu","year":"2001","journal-title":"Lancet"},{"key":"key20180108120947_b15-etm-03-02-0226","first-page":"79","article-title":"Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial","volume":"43","author":"Sciuto","year":"2002","journal-title":"J Nucl Med"},{"key":"key20180108120947_b16-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1200\/JCO.2005.01.2310","article-title":"Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy","volume":"23","author":"Tu","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108120947_b17-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1200\/jco.2010.28.15_suppl.4677","article-title":"Initial feasibility and safety results from a phase II\/III clinical trial to evaluate docetaxel (D) therapy in combination with zoledronic acid (ZA) \u00b1 strontium-89 (Sr89) in hormone-refractory prostate cancer patients","volume":"28","author":"Porfiri","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180108120947_b18-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1053-4296(00)80047-8","article-title":"Use of radionuclides for the palliation of bone metastases","volume":"10","author":"McEwan","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"key20180108120947_b19-etm-03-02-0226","first-page":"895","article-title":"Therapy of metastatic bone pain","volume":"42","author":"Serafini","year":"2001","journal-title":"J Nucl Med"},{"key":"key20180108120947_b20-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1259\/0007-1285-64-765-816","article-title":"Strontium-89 chloride for pain palliation in prostatic skeletal malignancy","volume":"64","author":"Laing","year":"1991","journal-title":"Br J Radiol"},{"key":"key20180108120947_b21-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s002590000315","article-title":"Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement","volume":"27","author":"Kraeber-Bod\u00e9r\u00e9","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"key20180108120947_b22-etm-03-02-0226","first-page":"219","article-title":"Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre\u2019s 10-year experience","volume":"13","author":"Windsor","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20180108120947_b23-etm-03-02-0226","first-page":"345","article-title":"Strontium-89 therapy for the pain of osseous metastases","volume":"26","author":"Silberstein","year":"1985","journal-title":"J Nucl Med"},{"key":"key20180108120947_b24-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.semnuclmed.2004.11.006","article-title":"Teletherapy and radiopharmaceutical therapy of painful bone metastases","volume":"35","author":"Silberstein","year":"2005","journal-title":"Semin Nucl Med"},{"key":"key20180108120947_b25-etm-03-02-0226","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/187152007781058596","article-title":"Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases","volume":"7","author":"Lam","year":"2007","journal-title":"Anticancer Agents Med Chem."}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2011.405\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T16:21:10Z","timestamp":1515428470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2011.405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,2]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,12,2]]},"published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.3892\/etm.2011.405"],"URL":"https:\/\/doi.org\/10.3892\/etm.2011.405","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,2]]}}}